Genetic determinants of cardiac hypertrophy
- 1 May 2008
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Cardiology
- Vol. 23 (3), 199-205
- https://doi.org/10.1097/hco.0b013e3282fc27d9
Abstract
Purpose of review Cardiac hypertrophy is a common phenotypic response of the heart to stimulants. It is associated with increased morbidity and mortality in various cardiovascular disorders. Genetic factors are important determinants of phenotypic expression of cardiac hypertrophy, whether in single-gene disorders or in complex traits. We focus on the molecular genetics of cardiac hypertrophy in various conditions with an emphasis on hypertrophic cardiomyopathy, a genetic paradigm of cardiac hypertrophic response. Recent findings The molecular genetic basis of cardiac hypertrophy in single-gene disorders has been partially elucidated. Likewise, the impact of genetics on the expression of cardiac hypertrophy in the general population has been demonstrated. Identification of mutations in the Z disk proteins has expanded the spectrum of causal mutations beyond the thin and thick filaments of the sarcomeres. In addition, modifier loci have been mapped and shown to impart considerable effects on the expression of cardiac hypertrophy in hypertrophic cardiomyopathy. Elucidation of the molecular genetics of sarcomeric hypertrophic cardiomyopathy and many of the phenocopies has highlighted the limitations of clinical diagnosis as a determinant of management and prognostic advice. The findings have raised the importance of diagnosis and treatment algorithms, which are based on both genotype and phenotype information. Summary Cardiac hypertrophy, regardless of the cause, is the phenotypic consequence of complex interactions between genetic and nongenetic factors.Keywords
This publication has 75 references indexed in Scilit:
- The Diploid Genome Sequence of an Individual HumanPLoS Biology, 2007
- Genome-wide mapping of modifier chromosomal loci for human hypertrophic cardiomyopathyHuman Molecular Genetics, 2007
- Myozenin 2 Is a Novel Gene for Human Hypertrophic CardiomyopathyCirculation Research, 2007
- Germline gain-of-function mutations in SOS1 cause Noonan syndromeNature Genetics, 2006
- Germline KRAS mutations cause Noonan syndromeNature Genetics, 2006
- Mutations inciscan confound genotype-phenotype correlations in hypertrophic cardiomyopathyJournal of Medical Genetics, 2001
- Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart StudyThe New England Journal of Medicine, 1990
- Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients.Circulation, 1982
- Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy.Circulation, 1981
- Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy.Circulation, 1979